Radiotherapy Market Forecast 2024-2029: Steady Growth at 5-6% CAGR by 2029
The global radiotherapy market is projected to grow at a CAGR of 5-6% over the next 5 years. The demand for advanced radiotherapy technologies is driven by the rising incidence of cancer, technological advancements in equipment and software, and expanding healthcare infrastructure across emerging markets. Additionally, the increasing focus on non-invasive treatment modalities and growing government funding for cancer care is contributing to the sector’s robust growth. To learn more about the research report, download a sample report.
Radiotherapy devices encompass a diverse array of technologies, including linear accelerators (Linacs), proton therapy systems, and brachytherapy equipment. These devices are essential in delivering targeted radiation to destroy cancerous cells while sparing surrounding healthy tissue. Modern radiotherapy treatments like stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) have revolutionized the field, offering more precise treatments with fewer side effects. The adoption of proton therapy, particularly in pediatric cancers and tumors near critical organs, has also gained traction. Proton therapy’s ability to precisely target cancerous tissues while minimizing exposure to healthy tissues is a significant advantage over traditional forms of radiotherapy, leading to its increased use across cancer centers globally.
To learn more about this report, download the PDF brochure
Replacement Sales Driving Growth in the Radiotherapy Market in the Developed Regions
Replacement sales are a key driver of growth in the radiotherapy market in developed regions. As advanced economies like the U.S., Canada, Germany, and Japan face aging installed bases of radiotherapy equipment, healthcare providers are increasingly focusing on replacing outdated systems with cutting-edge technologies. This trend is fueled by the growing need for more precise and efficient cancer treatment solutions. Equipment such as linear accelerators (LINACs), which are crucial for delivering radiation therapy, have a typical lifespan of 10-12 years. As these machines near the end of their operational life, hospitals and cancer centers are investing in new systems equipped with advanced features like real-time imaging, artificial intelligence, and stereotactic techniques. This not only improves treatment outcomes but also enhances workflow efficiency, contributing to the steady growth in radiotherapy equipment replacement sales across developed markets. Moreover, strict regulatory standards and reimbursement policies in these regions further push healthcare providers to upgrade to the latest available technologies.
The Rising Adoption in Emerging Markets
The expanding adoption of radiotherapy technologies in emerging markets, such as China, India, and Brazil, is driven by improvements in healthcare infrastructure, growing awareness of cancer treatments, and strong governmental support for cancer care programs. These countries are witnessing substantial investments in healthcare modernization and cancer treatment initiatives, leading to the rapid deployment of advanced radiotherapy equipment like linear accelerators (LINACs) and proton therapy systems. Government-sponsored programs are also playing a crucial role in making advanced cancer treatments accessible to larger populations. With increasing cancer incidence rates and greater focus on enhancing treatment outcomes, emerging markets are expected to demonstrate robust growth in radiotherapy adoption over the forecast period.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
Key players in the global radiotherapy market include Siemens (Varian), Elekta, ViewRay, RaySearch Laboratories, Accuray, IBA Worldwide, RefleXion Medical, Carl Zeiss, Optivus Proton Therapy, Intuitive Surgical, Inc. among others. Strategic acquisitions and product launch are two of the key strategies adopted by market players to strengthen their market position.
Radiotherapy Market Report Scope
|
Report Scope |
Details |
|
Base Year Considered |
2023 |
|
Historical Data |
2022 - 2023 |
|
Forecast Period |
2024 - 2029 |
|
Growth Rate |
CAGR of 5-6% |
|
Segment Scope |
Product Type, Applications, and End User |
|
Regional Scope |
|
|
Key Companies Mapped |
Siemens (Varian), Elekta, ViewRay, RaySearch Laboratories, Accuray, IBA Worldwide, RefleXion Medical, Carl Zeiss, Optivus Proton Therapy, Intuitive Surgical, Inc.; among others |
|
Report Highlights |
Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Key Strategic Questions Addressed
-
What is the market size & forecast of the radiotherapy market?
-
What are the historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the radiotherapy market?
-
What are the key trends defining the market?
-
What are the major factors impacting the market?
-
What are the opportunities prevailing in the market?
-
Which region holds the highest market share?
-
Which region is expected to witness the highest growth rate in the next 5 years?
-
Who are the major players in the market?
-
What are the key strategies adopted by market players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2023-2024)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Global Radiotherapy Market Snapshot (2023-2029)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Growing incidence of cancer cases
- Replacement sales driving growth in the developed markets
- Technological advancements in equipment and software
- Growing pool of patients treated with radiotherapy due to improving access
- Restraints/Challenges
- High equipment and maintenance cost
- Growing adoption of hypofractionation in the US and Europe
- Opportunities
- Emerging markets
- Key Market Trends
- Drivers
- Industry Speaks
- Market Dynamics
- Global Radiotherapy Market Size & Forecast (2022-2029), By Product Type, USD Billion
- Introduction
- Equipment
- Conventional Linacs (IMRT, IGRT, VMAT)
- Specialized Linacs (SRS, SBRT, MR guided RT)
- Proton Therapy
- Brachytherapy
- Others
- Software
- Treatment Planning Software (TPS)
- Oncology Information System Software (OIS)
- Others
- Services
- Radiotherapy Market Size & Forecast (2022-2029), By Applications, USD Billion
- Introduction
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Head and Neck Cancer
- Others
- Radiotherapy Market Size & Forecast (2022-2029), By End User, USD Billion
- Introduction
- Hospitals and Cancer Treatment Centers
- Freestanding Radiotherapy Centers
- Others
- Global Radiotherapy Market Size & Forecast (2022-2029), By Region, USD Billion
- Introduction
- North America Radiotherapy Market Size & Forecast (2022-2029), By Country, USD Billion
- US
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Canada
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- US
- Europe Radiotherapy Market Size & Forecast (2022-2029), By Country, USD Billion
- UK
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Germany
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- France
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Italy
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Spain
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Rest of Europe
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Asia Pacific (APAC) Radiotherapy Market Size & Forecast (2022-2029), By Country, USD Billion
- China
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Japan
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- India
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Rest of Asia Pacific
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Latin America (LATAM) Radiotherapy Market Size & Forecast (2022-2029), USD Billion
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Middle East & Africa (MEA) Radiotherapy Market Size & Forecast (2022-2029), USD Billion
- Market Size & Forecast, By Product Type (USD Billion)
- Market Size & Forecast, By Applications (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- China
- UK
- North America Radiotherapy Market Size & Forecast (2022-2029), By Country, USD Billion
- Introduction
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2023)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Siemens
- Elekta
- ViewRay
- RaySearch Laboratories
- Accuray
- IBA Worldwide
- RefleXion Medical
- Carl Zeiss
- Optivus Proton Therapy
- Intuitive Surgical, Inc.
- Other Prominent Players
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
Hospitals, Cancer Treatment Centers, Freestanding Radiotherapy Centers
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
